2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

»çȸ¹®Á¦¸¦ ÇØ°áÇϴ û³â 478¸íÀÇ ¡®º£À̽ºÄ·ÇÁ¡¯°¡ µÇ´Ù

10³â°£ 478¸íÀÇ ¼ö·á»ý ¹èÃ⡦ ÀÓÆÑÆ® »ýŰè ÀÎÀç µî¿ë¹® ¿ªÇÒ
ºñ¿µ¸® »ç´Ü¹ýÀÎ ·çÆ®ÀÓÆÑÆ®°¡ ‘ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ(Impact Basecamp)’ ÇÁ·Î±×·¥ 10ÁÖ³âÀ» ¸Â¾Æ ¼ö·á»ýÀÇ º¯È­¿Í ÇÁ·Î±×·¥ÀÇ ¼º°ú¸¦ ´ãÀº ÀÓÆÑÆ® ¸®Æ÷Æ®¸¦ ¹ß°£ÇÏ°í ±â³äÇà»ç¸¦ °³ÃÖÇß´Ù. ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ´Â û³âµéÀÌ »çȸ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿ª·®À» ±â¸£°í, À̸¦ Ä¿¸®¾î ¼ºÀå°ú ¿¬°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â ±³À° ÇÁ·Î±×·¥ÀÌ´Ù. ¾à 8ÁÖ~16ÁÖ°£ »çȸ¹®Á¦¸¦ Á¤ÀÇÇϰí Á÷Á¢ ¹®Á¦ ÇØ°á ¹æ¹ýÀ» µµÃâÇÏ´Â ÇÁ·ÎÁ§Æ® ±â¹Ý ÇнÀ(Project Based Learning, PBL) ¹æ½ÄÀ¸·Î ÁøÇàµÈ´Ù. 2015³â ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç±îÁö 478¸íÀÇ ¼ö·á»ýÀ» ¹èÃâ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
»ï¾ç»ç ¼­ºêÅ¥ Ä«Æä·¦, Ä¿ÇÇ¿Í ¹¶Ä§ Çö»ó Àû¾î ¶ó¶¼ ¾ÆÆ® ÀûÇÕ (2025-03-20)
KB±¹¹ÎÀºÇà, 2025³â 1ºÐ±â ÆÝµå ÆÇ¸Å ±Ô¸ð ÀºÇà±Ç 1À§ (2025-06-13)
¼¿¸®µå, ÁÖÁÖ¹èÁ¤ À¯»óÁõÀÚ ¹ßÇà°¡¾× 4260¿ø È®Á¤ (2025-06-13)
¡®À½¾ÇÀº ¼¼´ë¸¦ ³Ñ¾î È帥´Ù¡¯ ±èâ¿Ï¡¤±è±¤Áø (2025-07-10)
·Î·¹¾ËÆÄ¸®, ÇѼÒÈñ¿Í ÇÔ²² TVC Ä·ÆäÀÎ (2025-07-10)
±Ëµµ, ±èÁöÀ± ¹Ú»çµµ ÀÎÁ¤ÇÑ ¡®Á¤Ä¡ ºê·¹ÀΡ¯ ±Þ»ó½Â (2025-06-19)
¡°¼ö¹Ú ¾¾ ¹Ù¸¦ ¾Ë¹Ù¸ó ¸ðÁý¡±¡¦ÀÏ±Þ 100¸¸¿ø (2025-06-19)
¿öÅ͹㠹éÈ£, ½Å°î ¡®RUSH¡¯ µ¥Ä«Æ®·Ð ·¯´×¿þ¾î ·¯´× ¹«µå (2025-07-14)
¾Ï »ýÁ¸ÀÚ À§ÇÑ Á¾ÇÕÀûÀÌ°í »ç·Á ±íÀº Á÷Àå º¹±Í ÇÁ·Î±×·¥ (2025-02-09)
ÄíÄÜ, Â÷¼¼´ë ±ÝÀ¶ ÀÎÇÁ¶ó Çõ½Å °ßÀÎ (2025-07-16)
³ëº¸ÅØ, ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø°ú Àü·«Àû ÆÄÆ®³Ê½Ê ü°á (2025-03-03)
Áö¿ª¸íÀΠƯº°°ø¿¬ ¡®»ì¾ÆÀÖ´Â ½Ã°£, ±æ À§ÀÇ ¸íÀΡ¯ °³ÃÖ (2025-06-10)
½Ã¹ÎÀÌ Á÷Á¢ ±âȹÇÑ Çà»ç·Î È«»ç¿ë¹®È­°Å¸® ¹°µéÀδ٠(2025-06-14)
½Ç½Ã°£ Â÷·® µ¥ÀÌÅÍ ±â¹Ý »óǰ °³¹ß Çù¾à (2025-06-14)
Åø¹ÂÁ÷, Àå¾ÖÀÎ À½¾Ç°¡ Áø·Î Ç÷§ÆûÀ¸·Î ÀÚ¸®¸Å±è (2025-07-03)
¾ÆÇÁ¸®Ä«¿¡¼­ °¡Àå ³ôÀº °÷¿¡ ¼­½ÄÇÏ´Â °³±¸¸® ¹ß°ß (2025-07-20)
¡®µ¶¹ÚÁ ¾Æ½Ã¾Æ ÃÖ´ë ±Ô¸ð µ¿¹°¿ø¿¡¼­ ¸Å´ÏÀúµé°ú Èú¸µ (2025-04-11)
±èÀ±¾Æ, ¡°¼­¸® ´«¿¡¼­ ±¤¼±ÀÌ ³ª¿À³×?¡± ±â´ë (2025-06-20)
Źé-ÆÄÁÖ DMZ ¿¬°è ¡®¹®È­¡¤°ü±¤¡¤¹Ìµð¾î Ȱ¼ºÈ­¡¯ 3ÀÚ Çù¾à (2025-06-22)
Andersen Consulting Adds Collaborating Firm GMS (2025-07-22)
'º¸¹°¼¶' µµÁö¿ø, ¹ÝÀü ij¸¯ÅÍ... ±ØÀÇ ±äÀå°¨ ´õÇß´Ù (2025-04-10)
´ÚÅͶó¶ó, ¹Ý·Áµ¿¹° ÇǺΠ¹®Á¦ ÇØ°á À§ÇÑ Ç×Áø±Õ ÀÎÁõ (2025-06-24)
À½¾Ç¼ÎÇÁ ¾ÆÆ®Ç÷¹ÀÌÆ® ¾îµåº¥Ã³ (2025-06-24)
Çѱ¹·ÎŸ¸®, »êºÒ ÇÇÇØºÎÅÍ °¡Á¤ÀÇ ´Þ ºÀ»ç±îÁö (2025-06-13)
¡®ÀüÇö¹«°èȹ2¡¯ ±èÁ¾¹Î, ÀüÇö¹«-°ûÆ©ºê¿¡ ûøÀå Àü´Þ (2025-04-07)
       [ÀÌÀü][1]....[142][143][144][145][146][147][148][149][150]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..